PharVision Advisers’s Frontdoor FTDR Stock Holding History

PharVision Advisers’s Portfolio FTDR Stock Details FTDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,400	Closed	-$363K	–	796
2025 Q3	$363K	Buy	+5,400	New	+$329K	0.2%	120

Other funds holding FTDR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PharVision Advisers's FTDR Position: Q4 2025 in Review

PharVision Advisers sold out of Frontdoor (FTDR) in Q4 2025, closing a stake of 5,400 shares — an estimated $363K sold.

PharVision Advisers first reported a position in FTDR in Q3 2025 and held it in 1 quarter. The position peaked at $363K in Q3 2025. 354 funds tracked by Wall St. Rank hold FTDR as of Q4 2025.

PharVision Advisers reported no remaining Frontdoor position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 5,400 Frontdoor shares in Q4 2025, an estimated $363K.
PharVision Advisers first reported a position in Frontdoor in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Frontdoor position peaked at $363K in Q3 2025.
354 funds tracked by Wall St. Rank held Frontdoor as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.